ABL is pleased to announce a new collaboration with the New Zealand Liver Transplant Unit and LabPlus at Auckland City Hospital. This will evaluate the susceptibility to develop Hepatocellular Carcinoma (HCC) during 30 years follow-up, based on key baseline genomic variations of HBV in a large cohort of Maori.
Collaboration on HBV genomic variations and HCC
ABL and Mayo Medical Laboratories Ink Collaboration and Licensing Agreements
ABL and Mayo Medical Laboratories will develop novel innovative LDT and related IT in the field of virology. More details available here.
Renewal and extension with Roche Diagnostics International
Advanced Biological Laboratories (ABL) and Roche Diagnostics International renew and extend their collaboration agreement to promote their Next-Generation Sequencing, Genotyping and Drug Resistance Products. See the full press release.
DeepChek®-HIV Now Available in Illumina’s BaseSpace Apps
First virology application on BaseSpace to deal with HIV next generation sequencing coming from Illumina’s platforms. See the press release about BaseSpace and Illumina.
Exclusive licensing agreement with CRP-Santé for “COMET” software
ABL entered into an exclusive worldwide licensing agreement with CRP-Santé for its COMET software designed for high performance DNA sequencing analysis and classification.See full Press Release.